Girish Nadkarni of Avendus Capital feels that from a short-term perspective it is safe to buy some of the good quality domestic formulation companies in the pharma side.
first published: Jun 21, 2013 06:06 pm
A collection of the most-viewed Moneycontrol videos.
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
PM Modi Targets Congress After Women Reservation Bill Defeat, Vows To Remove Obstacles | FULL SPEECH
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
AMIT SHAH FULL SPEECH: Amit Shah Addresses Lok Sabha on Reservation, Delimitation & Representation
